Synthesis and evaluation of [67Ga]-AMD3100: A novel imaging agent for targeting the chemokine receptor CXCR4

Scientia Pharmaceutica

Volumn 82, Issue 1, 2014, Pages 29-42

  Aghanejad, Ayuob ^a,b   Jalilian, Amir R ^c   Fazaeli, Yousef ^c   Alirezapoor, Behrouz ^c   Pouladi, Mehraban ^c   Beiki, Davoud ^a,b   Maus, Stephan ^d   Khalaj, Ali ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Biodistribution; Breast carcinoma; CXCR4; Gallium 67; SPECT

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PLERIXAFOR; PLERIXAFOR GA 67; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG STABILITY; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGING; ISOTOPE LABELING; MOUSE; NONHUMAN; POLAROGRAPHY; RAT; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THIN LAYER CHROMATOGRAPHY;

EID: 84896878080     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1305-18     Document Type: Article

References (15)

1. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004; 4: 540-550. http://dx.doi.org/10.1038/nrc1388
2. Masuda M, Nakashima H, Ueda T, Naba H, Ikoma R, Otaka A, Terakawa Y, Tamamura H, Ibuka T, Murakami T, Koyanagi Y, Waki M, Matsumoto A, Yamamoto N, Funakoshi S, Fujii N. A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II). Biochem Biophys Res Commun. 1992; 189: 845-850. http://dx.doi.org/10.1016/0006-291X(92)92280-B
3. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L, Shim H. Silencing of CXCR4 Blocks Breast Cancer Metastasis. Cancer Res. 2005; 65: 967-971. http://www.ncbi.nlm.nih.gov/pubmed/15705897
4. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 2004; 64: 8604-8612. http://dx.doi.org/10.1158/0008-5472.CAN-04-1844
5. Gerlach LO, Jakobsen JS, Jensen KP, Rosenkilde MR, Skerlj RT, Ryde U, Bridger GJ, Schwartz TW. Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor. Biochemistry. 2003; 42: 710-717. http://dx.doi.org/10.1021/bi0264770
6. Knight JC, Hallett AJ, Brancale A, Paisey SJ, Clarkson RWE, Edwards PG. Evaluation of a Fluorescent Derivative of AMD3100 and its Interaction with the CXCR4 Chemokine Receptor. Chem Bio Chem. 2011; 12: 2692-2698. http://dx.doi.org/10.1002/cbic.201100441
7. Zhang JM, Tiana JH, Lia TR, Guo HY, Shen L. 99mTc-AMD3100: A novel potential receptor-targeting radiopharmaceutical for tumor imaging. Chin Chem Lett. 2010; 21: 461-463. http://dx.doi.org/10.1016/j.cclet.2009.12.018
8. Jacobson, Weiss ID, Szajek L, Farber J, Kiesewetter DO. 64Cu-AMD3100 - A novel imaging agent for targeting chemokine receptor CXCR4. Bioorg Med Chem. 2009; 17: 1486-1493. http://dx.doi.org/10.1016/j.bmc.2009.01.014
9. Nimmagadda S, Pullambhatla M, Stone K, Green G, Bhujwalla ZM, Pomper MG, Morgan RH. Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100-Positron Emission Tomography. Cancer Res. 2010; 70: 3935-3944. http://dx.doi.org/10.1158/0008-5472.CAN-09-4396
10. Firestone RB, Shirley VS, Baglin CM, Zipkin J. In: Table of isotopes.8th edition. John Wiley and Sons, p.1447, New York, 1996.
11. United States Pharmacopoeia 28, 2005, NF 23, p.1009.
12. United States Pharmacopoeia 28, 2005, NF 23, p.1895.
13. Woodard LE, Nimmagadda S. CXCR4-based imaging agents. J Nucl Med. 2011; 52: 1665-1669. http://dx.doi.org/10.2967/jnumed.111.097733
14. Nimmagadda S, Pullambhatla M, Pomper MG. Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT. J Nucl Med. 2009; 50: 1124-1130. http://dx.doi.org/10.2967/jnumed.108.061325
15. Jalilian AR, Rowshanfarzad P, Sabet M, Novinrooz A, Raisali G. Preparation of [66Ga]Bleomycin Complex as a Possible PET Radiopharmaceutical. J Radioanal Nucl Chem. 2005; 264: 617-622. http://dx.doi.org/10.1007/s10967-005-0761-2